Yan Chang Selected Research

Yan Chang Research Topics

Disease

26	Neoplasms (Cancer) 02/2024 - 04/2002
23	Experimental Arthritis 01/2023 - 02/2007
20	Arthritis (Polyarthritis) 07/2022 - 01/2011
18	Rheumatoid Arthritis 01/2024 - 09/2010
10	Inflammation (Inflammations) 03/2024 - 01/2013
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2001
9	Leukemia 01/2018 - 03/2001
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2006 - 06/2000
5	Chronic Obstructive Pulmonary Disease (COPD) 11/2023 - 01/2013
4	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 01/2011
4	Melanoma (Melanoma, Malignant) 03/2023 - 07/2008
4	Infections 01/2023 - 06/2009
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2011 - 03/2001
3	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 01/2020
3	Carcinogenesis 11/2022 - 04/2020
3	Esophageal Neoplasms (Esophageal Cancer) 02/2022 - 01/2018
3	Hypoxia (Hypoxemia) 10/2016 - 06/2009
3	Residual Neoplasm 08/2012 - 11/2005
2	Neuroblastoma 01/2024 - 07/2023
2	Cognitive Dysfunction 12/2023 - 01/2020
2	Disease Progression 12/2023 - 01/2021
2	Esophageal Squamous Cell Carcinoma 01/2023 - 02/2022
2	Osteoarthritis 01/2023 - 01/2023
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2022 - 12/2019
2	Coronary Disease (Coronary Heart Disease) 08/2022 - 07/2022
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2020 - 01/2018
2	Testicular Neoplasms (Testicular Cancer) 01/2020 - 12/2017
2	Necrosis 02/2019 - 12/2013
2	Multiple Myeloma 12/2017 - 09/2005
2	Breast Neoplasms (Breast Cancer) 04/2016 - 01/2002
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016 - 10/2015
2	Allergic Contact Dermatitis 02/2015 - 12/2013
2	Hepatocellular Carcinoma (Hepatoma) 05/2012 - 07/2010

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2002
9	Therapeutic UsesIBA 04/2023 - 05/2011
8	Messenger RNA (mRNA)IBA 01/2023 - 06/2001
7	Immunoglobulin D (IgD)IBA 02/2022 - 01/2016
6	AntigensIBA 01/2020 - 02/2002
6	peoniflorinIBA 08/2019 - 10/2011
6	GlucosidesIBA 08/2016 - 02/2007
5	Long Noncoding RNAIBA 01/2024 - 04/2020
5	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 05/2013
5	CalciumIBA 02/2022 - 01/2016
5	B-Cell Activating FactorIBA 06/2019 - 05/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2013 - 09/2001
4	Amyloid (Amyloid Fibrils)IBA 12/2023 - 01/2020
4	LigandsIBA 01/2023 - 05/2011
4	paeoniflorin-6'-O-benzenesulfonateIBA 07/2022 - 01/2016
4	Immunoglobulin G (IgG)IBA 10/2021 - 05/2011
4	CytokinesIBA 01/2021 - 12/2013
4	Monoclonal AntibodiesIBA 04/2016 - 10/2002
4	AntibodiesIBA 05/2012 - 10/2002
3	Interleukin-10 (Interleukin 10)IBA 03/2024 - 12/2013
3	Interleukin-4 (Interleukin 4)IBA 03/2024 - 12/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 09/2005
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2011
3	RNA (Ribonucleic Acid)IBA 03/2023 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2020
3	Interleukin-17 (Interleukin 17)IBA 02/2022 - 12/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 09/2010
3	G-Protein-Coupled Receptor Kinase 2IBA 12/2019 - 02/2019
3	Dinoprostone (PGE2)FDA Link 12/2019 - 11/2014
3	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2016 - 06/2009
3	20- O- (beta- D- glucopyranosyl)- 20(S)- protopanaxadiolIBA 07/2016 - 10/2014
3	TACI receptor-IgG Fc fragment fusion proteinIBA 05/2013 - 05/2011
2	Hemoglobins (Hemoglobin)IBA 04/2024 - 02/2007
2	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 03/2023
2	Antineoplastic Agents (Antineoplastics)IBA 03/2023 - 02/2022
2	Tryptophan (L-Tryptophan)FDA Link 01/2023 - 01/2022
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2023 - 07/2022
2	Epirubicin (Ellence)FDA LinkGeneric 01/2023 - 01/2018
2	KynurenineIBA 01/2023 - 01/2022
2	CreatinineIBA 11/2022 - 01/2013
2	U3 small nucleolar RNAIBA 11/2022 - 11/2021
2	Carrier Proteins (Binding Protein)IBA 11/2022 - 11/2021
2	Oxygen (Dioxygen)IBA 08/2022 - 07/2022
2	RP4010IBA 02/2022 - 01/2018
2	Peptides (Polypeptides)IBA 01/2020 - 01/2018
2	Cell Surface ReceptorsIBA 01/2020 - 12/2019
2	immunoglobulin D receptorIBA 12/2019 - 01/2016
2	ProstaglandinsIBA 08/2019 - 05/2012
2	Immunoglobulins (Immunoglobulin)IBA 06/2019 - 11/2017
2	Immunoglobulin A (IgA)IBA 01/2019 - 05/2012
2	NF-kappa B (NF-kB)IBA 01/2018 - 09/2005
2	IntegrinsIBA 01/2018 - 06/2000
2	Bortezomib (Velcade)FDA Link 12/2017 - 09/2005
2	Indicators and Reagents (Reagents)IBA 04/2016 - 07/2010
2	Caspase 3 (Caspase-3)IBA 08/2015 - 09/2005
2	Freund's AdjuvantIBA 03/2015 - 02/2015
2	Interleukin-2 (IL2)IBA 02/2015 - 12/2013
2	OzoneIBA 01/2015 - 01/2013
2	NucleophosminIBA 07/2013 - 02/2009

Therapy/Procedure

21	Therapeutics 02/2024 - 09/2005
9	Drug Therapy (Chemotherapy) 01/2024 - 06/2001
2	Intra-Articular Injections 01/2023 - 12/2013
2	Activities of Daily Living (ADL) 08/2022 - 08/2022
2	Immunotherapy 01/2020 - 04/2016
2	Intradermal Injections 03/2015 - 02/2015
2	Oral Administration 02/2015 - 05/2010